IBDEI1F1 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25105,1,5,0)
 ;;=5^RECTAL BLEEDING
 ;;^UTILITY(U,$J,358.3,25105,2)
 ;;=^55914
 ;;^UTILITY(U,$J,358.3,25106,0)
 ;;=592.0^^144^1563^4
 ;;^UTILITY(U,$J,358.3,25106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25106,1,2,0)
 ;;=2^592.0
 ;;^UTILITY(U,$J,358.3,25106,1,5,0)
 ;;=5^RENAL CALCULI
 ;;^UTILITY(U,$J,358.3,25106,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,25107,0)
 ;;=585.9^^144^1563^6
 ;;^UTILITY(U,$J,358.3,25107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25107,1,2,0)
 ;;=2^585.9
 ;;^UTILITY(U,$J,358.3,25107,1,5,0)
 ;;=5^RENAL FAILURE,CHRONIC
 ;;^UTILITY(U,$J,358.3,25107,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,25108,0)
 ;;=584.9^^144^1563^5
 ;;^UTILITY(U,$J,358.3,25108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25108,1,2,0)
 ;;=2^584.9
 ;;^UTILITY(U,$J,358.3,25108,1,5,0)
 ;;=5^RENAL FAILURE,ACUTE
 ;;^UTILITY(U,$J,358.3,25108,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,25109,0)
 ;;=714.0^^144^1563^7
 ;;^UTILITY(U,$J,358.3,25109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25109,1,2,0)
 ;;=2^714.0
 ;;^UTILITY(U,$J,358.3,25109,1,5,0)
 ;;=5^RHEUMATOID ARTHRITIS
 ;;^UTILITY(U,$J,358.3,25109,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,25110,0)
 ;;=460.^^144^1563^8
 ;;^UTILITY(U,$J,358.3,25110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25110,1,2,0)
 ;;=2^460.
 ;;^UTILITY(U,$J,358.3,25110,1,5,0)
 ;;=5^RHINITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,25110,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,25111,0)
 ;;=472.0^^144^1563^9
 ;;^UTILITY(U,$J,358.3,25111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25111,1,2,0)
 ;;=2^472.0
 ;;^UTILITY(U,$J,358.3,25111,1,5,0)
 ;;=5^RHINITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,25111,2)
 ;;=^24434
 ;;^UTILITY(U,$J,358.3,25112,0)
 ;;=726.90^^144^1564^1
 ;;^UTILITY(U,$J,358.3,25112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25112,1,2,0)
 ;;=2^726.90
 ;;^UTILITY(U,$J,358.3,25112,1,5,0)
 ;;=5^TENDONITIS
 ;;^UTILITY(U,$J,358.3,25112,2)
 ;;=^41010
 ;;^UTILITY(U,$J,358.3,25113,0)
 ;;=451.19^^144^1564^2
 ;;^UTILITY(U,$J,358.3,25113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25113,1,2,0)
 ;;=2^451.19
 ;;^UTILITY(U,$J,358.3,25113,1,5,0)
 ;;=5^THROMBOSIS/DVT
 ;;^UTILITY(U,$J,358.3,25113,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,25114,0)
 ;;=110.3^^144^1564^3
 ;;^UTILITY(U,$J,358.3,25114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25114,1,2,0)
 ;;=2^110.3
 ;;^UTILITY(U,$J,358.3,25114,1,5,0)
 ;;=5^TINEA CRURIS
 ;;^UTILITY(U,$J,358.3,25114,2)
 ;;=^33171
 ;;^UTILITY(U,$J,358.3,25115,0)
 ;;=110.4^^144^1564^4
 ;;^UTILITY(U,$J,358.3,25115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25115,1,2,0)
 ;;=2^110.4
 ;;^UTILITY(U,$J,358.3,25115,1,5,0)
 ;;=5^TINEA PEDIS
 ;;^UTILITY(U,$J,358.3,25115,2)
 ;;=^33168
 ;;^UTILITY(U,$J,358.3,25116,0)
 ;;=525.9^^144^1564^6
 ;;^UTILITY(U,$J,358.3,25116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25116,1,2,0)
 ;;=2^525.9
 ;;^UTILITY(U,$J,358.3,25116,1,5,0)
 ;;=5^TOOTHACHE
 ;;^UTILITY(U,$J,358.3,25116,2)
 ;;=^123871
 ;;^UTILITY(U,$J,358.3,25117,0)
 ;;=465.9^^144^1564^13
 ;;^UTILITY(U,$J,358.3,25117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25117,1,2,0)
 ;;=2^465.9
 ;;^UTILITY(U,$J,358.3,25117,1,5,0)
 ;;=5^URI,ACUTE
 ;;^UTILITY(U,$J,358.3,25117,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,25118,0)
 ;;=599.0^^144^1564^17
 ;;^UTILITY(U,$J,358.3,25118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25118,1,2,0)
 ;;=2^599.0
 ;;^UTILITY(U,$J,358.3,25118,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,25118,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,25119,0)
 ;;=597.80^^144^1564^12
 ;;^UTILITY(U,$J,358.3,25119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25119,1,2,0)
 ;;=2^597.80
 ;;^UTILITY(U,$J,358.3,25119,1,5,0)
 ;;=5^URETHRITIS NOS
 ;;
 ;;$END ROU IBDEI1F1
